Vantage Biosciences launched to take on diabetic eye disease by John Pinching | Jul 26, 2023 | News | 0 The new company’s core mission is to boost patient access to disease-modifying treatments Read More
Researchers find potential new target for eye disease therapy by Selina McKee | Apr 21, 2020 | News | 0 This research is the first to describe a role for SARM1 in photoreceptor cell biology Read More